Reportstack

VaxInnate Corporation - Product Pipeline Review - 2012 New REport

 

Naperville, IL -- (ReleaseWire) -- 09/26/2012 -- VaxInnate Corporation - Product Pipeline Review - 2012 provides data on the VaxInnate Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- VaxInnate Corporation - Brief VaxInnate Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of VaxInnate Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of VaxInnate Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the VaxInnate Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate VaxInnate Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of VaxInnate Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the VaxInnate Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with VaxInnate Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of VaxInnate Corporation and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of VaxInnate Corporation; VaxInnate Corporation - Key Therapeutics; VaxInnate Corporation - Pipeline Overview and Promising Molecules; VaxInnate Corporation - News; VaxInnate Corporation - Latest Updates; VaxInnate Corporation - Pipeline; VaxInnate Corporation - Discontinued/Dormant Projects

To view table of contents for this market report please visit:
http://www.reportstack.com/product/90018/vaxinnate-corporation-product-pipeline-review-2012.html